Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

ABSTRACT: Evaluate the safety and tolerability of RMC-6236 in adults with specific RAS mutant advanced solid tumors.

DISEASE(S): Adenocarcinoma,Lung Cancer,Colorectal Cancer (crc),Melanoma,Colorectal Cancer,Advanced Solid Tumors,Pancreatic Cancer,Lung Neoplasms,Non-small Cell Lung Cancer (nsclc),Pancreatic Ductal Adenocarcinoma (pdac),Nsclc,Colon Cancer,Non-small Cell Lung Cancer,Colorectal Neoplasms,Carcinoma, Non-small-cell Lung,Pancreatic Neoplasms,Colonic Neoplasms

PROVIDER: 2731011 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR